How to avoid local side effects of bladder photodynamic therapy: Impact of the fluence rate

Journal of Urology

Volumn 190, Issue 2, 2013, Pages 731-736

  François, Aurélie ^a,b,c   Salvadori, Aurélie ^c   Bressenot, Aude ^a   Bezdetnaya, Lina ^a,b,c   Guillemin, François ^a,b,c   D'Hallewin, Marie Ange ^a,b,c  

^a UNIVERSITÉ DE LORRAINE   (France)

^b CNRS   (France)

^c CENTRE ALEXIS VAUTRIN   (France)

Author keywords

5 aminolevulinic acid hexyl ester; complications; photochemotherapy; urinary bladder; urinary bladder neoplasms

Indexed keywords

AMINOLEVULINIC ACID HEXYL ESTER;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BLADDER TUMOR; BLADDER WALL; BLEACHING; CELL DEATH; CYSTALGIA; CYSTECTOMY; ILLUMINATION; INFLAMMATION; NONHUMAN; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; RAT; RED LIGHT; URINARY FREQUENCY; URINARY URGENCY; UROTHELIUM;

5-AMINOLEVULINIC ACID HEXYL ESTER; ALA; AMINOLEVULINIC ACID; CARCINOMA IN SITU; CIS; COMPLICATIONS; K; M/V; MASS PER VOLUME; PBS; PDT; PHOSPHATE BUFFERED SALINE; PHOTOBLEACHING CONSTANT; PHOTOCHEMOTHERAPY; PHOTODYNAMIC THERAPY; PPIX; PROTOPORPHYRIN IX; URINARY BLADDER; URINARY BLADDER NEOPLASMS;

AMINOLEVULINIC ACID; ANIMALS; APOPTOSIS; CYSTECTOMY; FEMALE; IMMUNOENZYME TECHNIQUES; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; RATS; RATS, INBRED F344; SPECTROMETRY, FLUORESCENCE; TUMOR CELLS, CULTURED; URINARY BLADDER NEOPLASMS;

EID: 84880043470     PISSN: 00225347     EISSN: 15273792     Source Type: Journal    
DOI: 10.1016/j.juro.2013.01.046     Document Type: Article

References (23)

1. P. Jichlinski Photodynamic applications in superficial bladder cancer: facts and hopes! J Environ Pathol Toxicol Oncol 25 2006 441
2. M.A. D'Hallewin, L. Baert Long-term results of whole bladder wall photodynamic therapy for carcinoma in situ of the bladder Urology 45 1995 763
3. J.J. Liu, M. Droller, J.C. Liao New optical imaging technologies for bladder cancer: considerations and perspectives J Urol 188 2012 361
4. D.C. Shackley, C. Briggs, A. Gilhooley Photodynamic therapy for superficial bladder cancer under local anaesthetic BJU Int 89 2002 665
5. A.P. Berger, H. Steiner, A. Stenzl Photodynamic therapy with intravesical instillation of 5-aminolevulinic acid for patients with recurrent superficial bladder cancer: a single-center study Urology 61 2003 338
6. R.J. Skyrme, A.J. French, S.N. Datta A phase-1 study of sequential mitomycin C and 5-aminolaevulinic acid-mediated photodynamic therapy in recurrent superficial bladder carcinoma BJU Int 95 2005 1206
7. R. Waidelich, W. Beyer, R. Knüchel Whole bladder photodynamic therapy with 5-aminolevulinic acid using a white light source Urology 61 2003 332
8. M.B. Ericson, C. Sandberg, B. Stenquist Photodynamic therapy of actinic keratosis at varying fluence rates: assessment of photobleaching, pain and primary clinical outcome Br J Dermatol 151 2004 1204
9. E.R.M. de Haas, B. Kruijt, H.J.C.M. Sterenborg Fractionated illumination significantly improves the response of superficial basal cell carcinoma to aminolevulinic-acid photodynamic therapy J Invest Dermatol 126 2006 2679
10. L. Vaucher, P. Jichlinski, N. Lange Hexyl-aminolevulinate-mediated photodynamic therapy: how to spare normal urothelium. An in vitro approach Lasers Surg Med 39 2007 67
11. S. El Khatib, J. Didelon, A. Leroux Kinetics, biodistribution and therapeutic efficacy of hexylester 5-aminolevulinate induced photodynamic therapy in an orthotopic rat bladder tumor model J Urol 172 2004 2013
12. S. Berrahmoune, N. Fotinos, L. Bezdetnaya Analysis of differential PDT effect in rat bladder tumor models according to concentrations of intravesical hexyl-aminolevulinate Photochem Photobiol Sci 7 2008 1018
13. Z. Xiao, T.J. McCallum, K.M. Brown Characterization of a novel transplantable orthotopic rat bladder transitional cell tumour model Br J Cancer 81 1999 638
14. A. Bressenot, S. Marchal, L. Bezdetnaya Assessment of apoptosis by immunohistochemistry to active caspase-3, active caspase-7, or cleaved PARP in monolayer cells and spheroid and subcutaneous xenografts of human carcinoma J Histochem Cytochem 57 2009 289
15. A.R. Kamuhabwa, A. Huygens, T. Roskams Enhancing the photodynamic effect of hypericin in human bladder transitional cell carcinoma spheroids by the use of the oxygen carrier, perfluorodecalin Int J Oncol 28 2006 775
16. F. Tomaselli, A. Maier, O. Sankin Acute effects of combined photodynamic therapy and hyperbaric oxygenation in lung cancer - a clinical pilot study Lasers Surg Med 28 2001 399
17. S. Coutier, L.N. Bezdetnaya, T.H. Foster Effect of irradiation fluence rate on the efficacy of photodynamic therapy and tumor oxygenation in meta-tetra (hydroxyphenyl) chlorin (mTHPC)-sensitized HT29 xenografts in nude mice Radiat Res 158 2002 339
18. W.J. Cottrell, A.D. Paguette, K.R. Keymel Irradiance-dependent photobleaching and pain in delta-aminolevulinic acid-photodynamic therapy of superficial basal cell carcinomas Clin Cancer Res 14 2008 4475
19. H. Wang, C. Ehnert, G.J. Brenner Bradykinin and peripheral sensitization Biol Chem 387 2006 11
20. A.C. Fabiyi, A.F. Brading The use of the isolated mouse whole bladder for investigating bladder overactivity J Pharmacol Exp Ther 319 2006 1386
21. J. Garrier, A. Bressenot, S. Gräfe Compartmental targeting for mTHPC-based photodynamic treatment in vivo: correlation of efficiency, pharmacokinetics, and regional distribution of apoptosis Int J Radiat Oncol Biol Phys 78 2010 563
22. S. Marchal, A. Fadloun, E. Maugain Necrotic and apoptotic features of cell death in response to Foscan photosensitization of HT29 monolayer and multicell spheroids Biochem Pharmacol 69 2005 1167
23. C.L. Parsons, M. Greenberger, L. Gabal The role of urinary potassium in the pathogenesis and diagnosis of interstitial cystitis J Urol 159 1998 1862